Patents by Inventor Gottfried Alber

Gottfried Alber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of IL-12 and IFN.alpha. for the treatment of infectious diseases
    Patent number: 5928636
    Abstract: The present invention provides a combination of IL-12 and IFN.alpha. together with a pharmaceutically acceptable carrier useful for treatment and prophylaxis of infectious diseases, preferably chronic infectious diseases and more preferably viral infections, e.g. HSV, HIV, Hepatitis B, Hepatitis C, papilloma etc., bacterial infections, e.g. tuberculosis, salmonellosis, listeriosis, etc., and parasite infections, e.g. malaria, leishmaniasis, and schistosomiasis. These compositions are characterized by the synergistic interaction of IL-12 and IFN.alpha.. The present invention also provides the use of the above combination for the treatment and prophylaxis of infectious diseases.
    Type: Grant
    Filed: April 30, 1997
    Date of Patent: July 27, 1999
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Gottfried Alber, Jacqueline Anne Carr, Frank Albert Mattner, Michael John Mulqueen, Kathrin Palmer, Jane Andre Louise Rogerson
  • Compositions of G-CSF and TNF-BP for prophylaxis and treatment of septic shock
    Patent number: 5776895
    Abstract: The present invention is directed to products containing G-CSF and a TNF binding protein and compositions of G-CSF and TNF-BP, and methods of treating and/or preventing septic shock by administering the products and compositions of the invention.
    Type: Grant
    Filed: January 23, 1995
    Date of Patent: July 7, 1998
    Assignee: Hoffman-La Roche Inc.
    Inventors: Gottfried Alber, Peter Angehrn
  • Compositions of G-CSF and TNF-BP for prophylaxis and treatment of septic shock
    Patent number: 5750503
    Abstract: The present invention is directed to products containing G-CSF and a TNF binding protein and compositions of G-CSF and TNF-BP, and methods of treating and/or preventing septic shock by administering the products and compositions of the invention.
    Type: Grant
    Filed: May 5, 1995
    Date of Patent: May 12, 1998
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Gottfried Alber, Peter Angehrn